Acadia Pharmaceuticals Inc (ACAD)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Baker Bros. Advisors

Julian Baker And Felix Baker

42,864,612 $1,342,091,002 15.27%
2.
EcoR1 Capital

Oleg Nodelman

5,991,479 $187,593,207 4.87%
3.
D E Shaw

D. E. Shaw

3,754,598 $117,556,464 -22% 0.1%
4.
Palo Alto Investors

William Leland Edwards

2,409,556 $75,443,198 +1% 6.79%
5.
Millennium Management

Israel Englander

1,764,678 $55,252,068 -27% 0.02%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$25.65 259,109 Large Shareholder, Director 39,317,673 2023-05-24 Filing
$25.65 24,113 Large Shareholder, Director 3,610,443 2023-05-24 Filing
$25.51 28,878 Large Shareholder, Director 39,058,564 2023-05-24 Filing
$25.51 2,688 Large Shareholder, Director 3,586,330 2023-05-24 Filing
$25.27 218,171 Large Shareholder, Director 39,029,686 2023-05-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$24.67 772 21,067 2024-02-26 Filing
$24.67 624 31,432 2024-02-26 Filing
$24.67 474 11,391 2024-02-26 Filing
$24.67 5,577 101,890 2024-02-26 Filing
$29.96 3,732 Officer, Director 96,521 2024-01-08 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 13,396,009 $419,429,041 0%
2. 11,410,483 $357,262,222 0%
3. 11,253,551 $352,348,682 5.5%
4. 6,465,026 $202,419,964 0%
5. 5,265,358 $164,858,357 0.01%
News See All